We May be Overlooking a Critical Factor: Antiquated Endpoint Design…The reason why oncology trials in particular are increasing in duration is because standard of care (SOC) treatment options are soo good at prolonging life, however, regulators and payers still require that an oncology study’s primary endpoint focus on patient death. (AppliedClinicalTrials Online)